Projects per year
Abstract
Bioluminescence resonance energy transfer (BRET) is a biophysical technique used to monitor proximity within live cells. BRET exploits the naturally occurring phenomenon of dipole-dipole energy transfer from a donor enzyme (luciferase) to an acceptor fluorophore following enzyme-mediated oxidation of a substrate. This results in production of a quantifiable signal that denotes proximity between proteins and/or molecules tagged with complementary luciferase and fluorophore partners. BRET assays have been used to observe an array of biological functions including ligand binding, intracellular signaling, receptor-receptor proximity, and receptor trafficking, however, BRET assays can theoretically be used to monitor the proximity of any protein or molecule for which appropriate fusion constructs and/or fluorophore conjugates can be produced. Over the years, new luciferases and approaches have been developed that have increased the potential applications for BRET assays. In particular, the development of the small, bright and stable Nanoluciferase (NanoLuc; Nluc) and its use in NanoBRET has vastly broadened the potential applications of BRET assays. These advances have exciting potential to produce new experimental methods to monitor protein-protein interactions (PPIs), protein-ligand interactions, and/or molecular proximity. In addition to NanoBRET, Nluc has also been exploited to produce NanoBiT technology, which further broadens the scope of BRET to monitor biological function when NanoBiT is combined with an acceptor. BRET has proved to be a powerful tool for monitoring proximity and interaction, and these recent advances further strengthen its utility for a range of applications.
Original language | English |
---|---|
Article number | 56 |
Number of pages | 13 |
Journal | Frontiers in Bioengineering and Biotechnology |
Volume | 7 |
Issue number | MAR |
DOIs | |
Publication status | Published - 26 Mar 2019 |
Fingerprint
Dive into the research topics of 'NanoBRET: The Bright Future of Proximity-Based Assays'. Together they form a unique fingerprint.Projects
- 3 Finished
-
Development of technologies to monitor multimolecular complexes
Pfleger, K. (Investigator 01), Rosengren, K. (Investigator 02), Hill, S. (Investigator 03), Abbenante, G. (Investigator 04), Wood, K. (Investigator 05) & Williams, J. (Investigator 06)
ARC Australian Research Council , BMG Labtech Pty Ltd, Dimerix Bioscience Pty Ltd, Promega Corporation
1/01/16 → 2/11/19
Project: Research
-
Molecular pharmacology of chemokine receptor signalling in cancer
White, C. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/15 → 31/12/21
Project: Research
-
The molecular pharmacology of receptor complexes
Pfleger, K. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/15 → 31/12/18
Project: Research
Research output
- 121 Citations
- 1 Doctoral Thesis
-
An in-depth investigation of orexin receptor pharmacology profiled using advanced Bioluminescence Resonance Energy Transfer (BRET) techniques
Dale, N., 2022, (Unpublished)Research output: Thesis › Doctoral Thesis
File125 Downloads (Pure)